Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to 0.0.

  • Abeona Therapeutics' Asset Utilization Ratio changed N/A to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year change of. This contributed to the annual value of 0.05 for FY2023, which is 17761.01% up from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Asset Utilization Ratio is 0.0.
  • In the past 5 years, Abeona Therapeutics' Asset Utilization Ratio registered a high of 0.07 during Q2 2023, and its lowest value of 0.04 during Q4 2021.
  • For the 5-year period, Abeona Therapeutics' Asset Utilization Ratio averaged around 0.02, with its median value being 0.03 (2022).
  • Within the past 5 years, the most significant YoY rise in Abeona Therapeutics' Asset Utilization Ratio was 150808.61% (2021), while the steepest drop was 16625.82% (2021).
  • Over the past 5 years, Abeona Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.04 in 2021, then surged by 174.84% to 0.03 in 2022, then surged by 95.93% to 0.05 in 2023, then fell by 6.3% to 0.05 in 2024, then crashed by 96.68% to 0.0 in 2025.
  • Its last three reported values are 0.0 in Q3 2025, 0.0 for Q2 2025, and 0.05 during Q1 2024.